验方“甲眼康”治疗甲状腺相关性眼病的临床研究.pdf

《验方“甲眼康”治疗甲状腺相关性眼病的临床研究.pdf》由会员上传分享，免费在线阅读，更多相关内容在应用文档-天天文库。

1、《中外医学研究》第12卷第15期(总第239J*J])2014~5月经验体会Jingyantihu验方“甲眼康’’治疗甲状腺相关性眼病的临床研究谢宇明①卢集森①周少琚①谢秀莹①【摘要】目的：观察验方“甲眼康”治疗甲状腺相关性眼病的疗效。方法：将2005—2007年笔者所在医院门诊及住院的58例甲状腺相关性眼病患者，随机分为对照组28例和试验组3O例。对照组进行常规的甲亢治疗，试验组在对照组的基础上加用验方“甲眼康”。观察并比较两组的治疗效果。结果：试验组总有效率为83-3％，对照组为39．3％，两组

2、比较差异有统计学意义(P

3、ankangintheTreatmentofThyroidAssociatedOphthalmopathy／XIEYu-ming，LUJi—sen．ZHOUShao-jan。etalJ／ChineseandForeignMedicalResearch。2014，12(15)：119-120【Abstract】Objective：ToobservethecurativeefectofprescriptionsJiayankanginthetreatmentofthyroidassociatedopht

4、halmopathy．Method：58CSSeSofthyroidassociatedophthalmopathyinourhospitalofoutpatientandhospitalizationfrom2005to2007wererandomlydividedintocontrolgroup28casesandexperimentalgroup30cases．Thecontrolgrouptreatedwithroutinetreatmentofhyperthyroidism，theexpe

5、rimentalgroupusedprescriptionsJiayankangonthebasisofthecontrolgroup．Toobserveandcomparethetherapeuticefectoftwogroups．Result：ThetotalefectiverateofexperimentalgroupWas83-3％．itwas39．3％inthecontrolgroup，thediferencewasstatisticallysignificant(P

6、effectiverateofclassI(mild)，classⅡ(moderate)andthelevelII1(serious)in-theexperimentalgroupwere100％，92．9％and33-3％respectively，thecontrolgroupwere53．8％，33_3％and0，respectively．Conclusion：TheprescriptionJiayankanghasagoodeficacyandhighsafetyinthetreatmento

7、fthyroidassociatedophthalmopathy，especiallyforpatientswithmildtomoderatethyroidassociatedeyedisease．【KeywordslSmooththeliverandregulatetheqi-flow；Reducingphlegmandresolvingmasses；Replenishingthevitalessenceandremnvingheat；Thyroidassociatedophthalmopath

8、yFirst-author’Saddress：GuangzhouLiwanDistrictHospitalofTraditionalChineseMedicine，Guangzhou510140，China甲状腺相关眼病是一种自身免疫性疾病，多发于中年人，居1．2诊断标准眼眶病首位[1】。祖国医学对其早有认识，将之统称为“鹘眼凝睛”，参照《实用眼科诊断学》及《眼眶病学》的诊断标准[2-3]。认为甲亢突眼的发生因肝郁气滞，导致气郁血瘀、肝郁犯脾、脾甲亢突眼症诊断分类标准